LCP
Lamond Capital Partners Portfolio holdings
AUM
$14.3M
This Quarter Return
-3.58%
1 Year Return
-19.1%
3 Year Return
+80.95%
5 Year Return
–
10 Year Return
–
AUM
$14.3M
AUM Growth
+$14.3M
(-79%)
Cap. Flow
-$52M
Cap. Flow
% of AUM
-364.13%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
6
Top Buys
No buys this quarter
Top Sells
| 1 |
Oracle
ORCL
|
$18.3M |
| 2 |
Puma Biotechnology
PBYI
|
$17.3M |
| 3 |
Amgen
AMGN
|
$12.2M |
| 4 |
AbbVie
ABBV
|
$2.86M |
| 5 |
RXDX
Ignyta, Inc.
RXDX
|
$626K |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AbbVie
ABBV
$372B
| $14.3M | 100% |
250,000
-50,000
| -17% | -$2.86M |
|
|
2
Amgen
AMGN
$155B
| – | – |
-75,000
| Closed | -$12.2M |
|
|
3
Oracle
ORCL
$635B
| – | – |
-500,000
| Closed | -$18.3M |
|
|
4
Puma Biotechnology
PBYI
$254M
| – | – |
-220,780
| Closed | -$17.3M |
|
|
IMMU
5
DELISTED
Immunomedics Inc
IMMU
| – | – |
-100,000
| Closed | -$307K |
|
|
RXDX
6
DELISTED
Ignyta, Inc.
RXDX
| – | – |
-46,721
| Closed | -$626K |
|
|
ZLTQ
7
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| – | – |
-16,119
| Closed | -$460K |
|